Talis Biomedical Corporation (TLIS)
- Previous Close
9.10 - Open
9.07 - Bid --
- Ask --
- Day's Range
9.20 - 9.20 - 52 Week Range
4.35 - 9.32 - Volume
50 - Avg. Volume
9,174 - Market Cap (intraday)
16.763M - Beta (5Y Monthly) 1.74
- PE Ratio (TTM)
-- - EPS (TTM)
-34.12 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. The company was incorporated in 2013 and is headquartered in Chicago, Illinois.
talisbio.comRecent News: TLIS
Performance Overview: TLIS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TLIS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TLIS
Valuation Measures
Market Cap
16.76M
Enterprise Value
-40.30M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
40.59
Price/Book (mrq)
0.24
Enterprise Value/Revenue
-97.81
Enterprise Value/EBITDA
0.61
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.33%
Return on Equity (ttm)
-63.32%
Revenue (ttm)
2.13M
Net Income Avi to Common (ttm)
-62.01M
Diluted EPS (ttm)
-34.12
Balance Sheet and Cash Flow
Total Cash (mrq)
76.73M
Total Debt/Equity (mrq)
28.46%
Levered Free Cash Flow (ttm)
-36.33M